Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meagan Jacoby

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Annals of Hematology|March 1, 2017
Virescent tongueAlaa M Ali, Meagan Jacoby, Rizwan Romee
Annals of Hematology|November 7, 2015
Hand-foot syndrome following decitabineAlaa M Ali, Meagan Jacoby, John S Welch
American Journal of Hematology|April 12, 2014
A phase I dose escalation study of oral bexarotene in combination with intravenous decitabine in patients with AMLJohn S Welch, Haixia Niu, Geoffrey L Uy, et al.
Cancer Genetics|December 6, 2023
Clinical whole-genome sequencing and FISH identify two different fusion partners for NUP98 in a patient with acute myeloid leukemia: A case reportBahareh A Mojarad, Zachary D Crees, Molly C Schroeder, et al.
JAMA Oncology|December 13, 2019
Comparison of Patient Age Groups in Transplantation for Myelodysplastic Syndrome: The Medicare Coverage With Evidence Development StudyEhab Atallah, Brent Logan, Min Chen, et al.
Leukemia Research|August 10, 2016
Phase I study of azacitidine following donor lymphocyte infusion for relapsed acute myeloid leukemia post allogeneic stem cell transplantationArmin Ghobadi, Jaebok Choi, Mark A Fiala, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 15, 2013
Protective effect of cytomegalovirus reactivation on relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients is influenced by conditioning regimenShivaprasad Manjappa, Pavan Kumar Bhamidipati, Keith E Stokerl-Goldstein, et al.
Blood|December 6, 2017
Safety and efficacy of selinexor in relapsed or refractory multiple myeloma and Waldenstrom macroglobulinemiaChristine Chen, David Siegel, Martin Gutierrez, et al.
Blood|May 5, 2017
Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin lymphomaJohn Kuruvilla, Michael Savona, Rachid Baz, et al.
Blood|November 22, 2024
Itacitinib for prevention of graft-versus-host disease and cytokine release syndrome in haploidentical transplantationRamzi Abboud, Mark A Schroeder, Michael P Rettig, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Annals of Hematology|March 1, 2017
Virescent tongueAlaa M Ali, Meagan Jacoby, Rizwan Romee
Annals of Hematology|November 7, 2015
Hand-foot syndrome following decitabineAlaa M Ali, Meagan Jacoby, John S Welch
American Journal of Hematology|April 12, 2014
A phase I dose escalation study of oral bexarotene in combination with intravenous decitabine in patients with AMLJohn S Welch, Haixia Niu, Geoffrey L Uy, et al.
Cancer Genetics|December 6, 2023
Clinical whole-genome sequencing and FISH identify two different fusion partners for NUP98 in a patient with acute myeloid leukemia: A case reportBahareh A Mojarad, Zachary D Crees, Molly C Schroeder, et al.
JAMA Oncology|December 13, 2019
Comparison of Patient Age Groups in Transplantation for Myelodysplastic Syndrome: The Medicare Coverage With Evidence Development StudyEhab Atallah, Brent Logan, Min Chen, et al.
Leukemia Research|August 10, 2016
Phase I study of azacitidine following donor lymphocyte infusion for relapsed acute myeloid leukemia post allogeneic stem cell transplantationArmin Ghobadi, Jaebok Choi, Mark A Fiala, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 15, 2013
Protective effect of cytomegalovirus reactivation on relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients is influenced by conditioning regimenShivaprasad Manjappa, Pavan Kumar Bhamidipati, Keith E Stokerl-Goldstein, et al.
Blood|December 6, 2017
Safety and efficacy of selinexor in relapsed or refractory multiple myeloma and Waldenstrom macroglobulinemiaChristine Chen, David Siegel, Martin Gutierrez, et al.
Blood|May 5, 2017
Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin lymphomaJohn Kuruvilla, Michael Savona, Rachid Baz, et al.
Blood|November 22, 2024
Itacitinib for prevention of graft-versus-host disease and cytokine release syndrome in haploidentical transplantationRamzi Abboud, Mark A Schroeder, Michael P Rettig, et al.
Pageof 2